Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis–related interstitial lung diseases: a retrospective, observational cohort study

被引：0
|
作者：
Deniz Demir Yılmaz
Sermin Borekci
Benan Musellim
机构：
[1] Istanbul University-Cerrahpasa,Department of Pulmonary Diseases, Cerrahpasa Medical Faculty
来源：
Clinical Rheumatology | 2021年 / 40卷
关键词：
Cyclophosphamide; Rituximab; Systemic sclerosis–related interstitial lung diseases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4071 / 4079
页数：8
相关论文
共 50 条
  • [1] Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study
    Yilmaz, Deniz Demir
    Borekci, Sermin
    Musellim, Benan
    CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 4071 - 4079
  • [2] Rituximab and Cyclophosphamide in Antisynthetase Syndrome-related Interstitial Lung Disease: An Observational Retrospective Study
    Langlois, Vincent
    Gillibert, Andre
    Uzunhan, Yurdagul
    Chabi, Marie-Laure
    Hachulla, Eric
    Landon-Cardinal, Oceane
    Mariampillai, Kuberaka
    Champtiaux, Nicolas
    Nunes, Hilario
    Benveniste, Olivier
    Hervier, Baptiste
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (11) : 1678 - 1686
  • [3] Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
    Mohammed, Abdel Gaffar A.
    Alshihre, Ammar
    Al-Homood, Ibrahim Abdulrazag
    ANNALS OF THORACIC MEDICINE, 2017, 12 (04) : 294 - 297
  • [4] Efficacy of Rituximab Versus Cyclophosphamide and Mycophenolate for the Treatment of Interstitial Lung Disease in Systemic Sclerosis: A Systematic Review
    Parikh, Aneri
    Francis, Aida J.
    Sreenivasan, Chithra
    Pandey, Manorama
    AlQassab, Osamah
    Kanthajan, Tatchaya
    AlEdani, Esraa M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [5] Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Sim, Myung
    Li, Ning
    Khanna, Dinesh
    Roth, Michael D.
    Clements, Philip J.
    Hoffmann-Vold, Anna-Maria
    Furst, Daniel E.
    Kim, Grace
    Goldin, Jonathan
    Elashoff, Robert M.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (10) : 1316 - 1325
  • [6] COMPARISON OF THE EFFICACY AND SAFETY OF CYCLOPHOSPHAMIDE (SP) AND RITUXIMAB (RTM) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    CHEST, 2020, 157 (06) : 373A - 373A
  • [7] A retrospective observational study of rituximab treatment in multiple sclerosis patients in Cyprus
    Leonidou, Eleni
    Pantzaris, Marios
    Kleopa, Kleopas A.
    Loizidou, Maria A.
    Kyriakides, Theodoros
    Christou, Yiolanda P.
    POSTGRADUATE MEDICINE, 2019, 131 (07) : 486 - 489
  • [8] Effects of cyclophosphamide and rituximab in patients with connective tissue diseases with severe interstitial lung disease
    Benad, M.
    Koschel, D.
    Herrmann, K.
    Wiefel, K.
    Kleymann, A.
    Aringer, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (03) : 483 - 488
  • [9] Rituximab treatment for systemic sclerosis-associated interstitial lung disease: a case series of 13 patients
    Morgan, Kelly
    Woollard, Charlotte
    Beinart, Dylan
    Host, Lauren, V
    Roddy, Janet
    INTERNAL MEDICINE JOURNAL, 2023, 53 (07) : 1147 - 1153
  • [10] Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
    Goswami, Rudra P.
    Ray, Animesh
    Chatterjee, Moumita
    Mukherjee, Arindam
    Sircar, Geetabali
    Ghosh, Parasar
    RHEUMATOLOGY, 2021, 60 (02) : 557 - 567
12345